This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Daewoong Pharmaceutical Co., Ltd.. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Innovations of Joon-Hwan Lee in Pharmaceutical Crystallization
Introduction
Joon-Hwan Lee is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the crystallization of compounds. His work focuses on enhancing the efficiency and selectivity of pharmaceutical processes.
Latest Patents
Joon-Hwan Lee holds a patent for a method for selectively crystallizing a Z isomer of iopromide. The patent describes a process that involves dissolving a crude iopromide mixture in an alcohol and subsequently heating the solution to obtain crystalline Z isomer of iopromide. This innovative method not only improves the purity of the Z isomer but also facilitates the preparation of compositions containing this crystalline form.
Career Highlights
Lee is associated with Daewoong Pharmaceutical Co., Ltd., where he applies his expertise in pharmaceutical development. His work has contributed to advancements in drug formulation and delivery systems. With a focus on innovative solutions, he continues to push the boundaries of pharmaceutical science.
Collaborations
Throughout his career, Joon-Hwan Lee has collaborated with talented professionals, including Soo-Jin Choi and Byung-Goo Lee. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking technologies.
Conclusion
Joon-Hwan Lee's contributions to the field of pharmaceutical crystallization exemplify the impact of innovation in drug development. His patented methods enhance the efficiency of producing essential pharmaceutical compounds, showcasing the importance of inventors in advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
